HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

AD 20 (AD-20)

designed to reduce toxicity or enhance activity of anticancer drugs
Also Known As:
AD-20; AD20; N-(2-methoxyphenylacetyl)dehydroalanine; 2-Propenoic acid, 2-(((2-methoxyphenyl)acetyl)amino)-
Networked: 34 relevant articles (0 outcomes, 3 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Petersen, Ronald C: 2 articles (02/2015 - 03/2011)
2. Van Laere, Koen: 2 articles (01/2013 - 09/2010)
3. Nelissen, Natalie: 2 articles (01/2013 - 09/2010)
4. Vandenberghe, Rik: 2 articles (01/2013 - 09/2010)
5. Ivanoiu, Adrian: 2 articles (01/2013 - 09/2010)
6. Minthon, Lennart: 2 articles (01/2013 - 09/2010)
7. Andersen, Allan: 2 articles (01/2013 - 09/2010)
8. Korner, Alex: 2 articles (01/2013 - 09/2010)
9. Hasselbalch, Steen: 2 articles (01/2013 - 09/2010)
10. Salmon, Eric: 2 articles (01/2013 - 09/2010)

Related Diseases

1. Parkinson Disease (Parkinson's Disease)
2. Alzheimer Disease (Alzheimer's Disease)
3. Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
4. Psoriasis (Pustulosis Palmaris et Plantaris)
5. Dementia (Dementias)

Related Drugs and Biologics

1. 9-fluoropropyldihydrotetrabenazine
2. Chemokine CCL24
3. Interleukin-1beta (Interleukin 1 beta)
4. E-Selectin
5. Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
6. Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
7. Cytokine Receptors (Cytokine Receptor)
8. N-Methylaspartate (NMDA)
9. Messenger RNA (mRNA)
10. Plasminogen

Related Therapies and Procedures

1. Transcutaneous Electric Nerve Stimulation (TENS)
2. Drug Therapy (Chemotherapy)